Atlas Trials

Study of the Combination of Panobinostat & Carfilzomib in Patients With Relapsed &/or Refractory Multiple Myeloma

Clinical trial NCT01549431 · COMPLETED

Trial details

NCT number
NCT01549431
Sponsor
Emory University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2012-01-01
Primary completion
2016-02-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.